Director, HTA Value and Evidence
Pfizer Inc.
Disclosure(s): Pfizer Inc: Employee of Pfizer and may hold stock or stock options of Pfizer
Dr. Yehoshua works as Director of mRNA HTA Value and Evidence at Pfizer. He has over 12 years of Health Economics and Outcomes Research / Real World Evidence (HEOR/RWE) experience including database analysis, and over 3 years of experience conducting research in infectious diseases. Other therapeutics areas of research include urology, neurology, nephrology, bone, inflammation, and liver disease. He has led numerous HEOR/RWE activities and HTA submissions for products globally, with a strong focus on the US.